PROCTER & GAMBLE HEALTH | ALEMBIC PHARMA | PROCTER & GAMBLE HEALTH/ ALEMBIC PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.4 | 32.1 | 107.1% | View Chart |
P/BV | x | 10.5 | 4.4 | 238.4% | View Chart |
Dividend Yield | % | 2.0 | 0.8 | 247.5% |
PROCTER & GAMBLE HEALTH ALEMBIC PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ALEMBIC PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ ALEMBIC PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 792 | 677.2% | |
Low | Rs | 3,883 | 463 | 838.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 287.6 | 257.6% | |
Earnings per share (Unadj.) | Rs | 138.2 | 17.4 | 794.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 31.4 | 494.0% | |
Dividends per share (Unadj.) | Rs | 95.00 | 8.00 | 1,187.5% | |
Avg Dividend yield | % | 2.1 | 1.3 | 161.2% | |
Book value per share (Unadj.) | Rs | 447.6 | 222.3 | 201.3% | |
Shares outstanding (eoy) | m | 16.60 | 196.56 | 8.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.2 | 286.0% | |
Avg P/E ratio | x | 33.5 | 36.1 | 92.7% | |
P/CF ratio (eoy) | x | 29.8 | 20.0 | 149.1% | |
Price / Book Value ratio | x | 10.3 | 2.8 | 365.9% | |
Dividend payout | % | 68.7 | 46.0 | 149.5% | |
Avg Mkt Cap | Rs m | 76,761 | 123,402 | 62.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 11,691 | 17.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 56,526 | 21.8% | |
Other income | Rs m | 184 | 30 | 604.9% | |
Total revenues | Rs m | 12,480 | 56,557 | 22.1% | |
Gross profit | Rs m | 3,247 | 6,772 | 47.9% | |
Depreciation | Rs m | 281 | 2,754 | 10.2% | |
Interest | Rs m | 8 | 502 | 1.5% | |
Profit before tax | Rs m | 3,142 | 3,546 | 88.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 126 | 671.9% | |
Profit after tax | Rs m | 2,295 | 3,420 | 67.1% | |
Gross profit margin | % | 26.4 | 12.0 | 220.4% | |
Effective tax rate | % | 27.0 | 3.6 | 758.3% | |
Net profit margin | % | 18.7 | 6.1 | 308.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 29,139 | 40.2% | |
Current liabilities | Rs m | 6,791 | 16,408 | 41.4% | |
Net working cap to sales | % | 40.0 | 22.5 | 177.7% | |
Current ratio | x | 1.7 | 1.8 | 97.1% | |
Inventory Days | Days | 263 | 10 | 2,711.7% | |
Debtors Days | Days | 343 | 7 | 5,083.3% | |
Net fixed assets | Rs m | 10,617 | 31,498 | 33.7% | |
Share capital | Rs m | 166 | 393 | 42.2% | |
"Free" reserves | Rs m | 7,265 | 43,312 | 16.8% | |
Net worth | Rs m | 7,431 | 43,705 | 17.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 60,637 | 36.8% | |
Interest coverage | x | 409.1 | 8.1 | 5,070.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.9 | 59.1% | |
Return on assets | % | 10.3 | 6.5 | 159.4% | |
Return on equity | % | 30.9 | 7.8 | 394.7% | |
Return on capital | % | 42.4 | 9.3 | 457.7% | |
Exports to sales | % | 0 | 46.4 | 0.0% | |
Imports to sales | % | 13.1 | 12.1 | 107.8% | |
Exports (fob) | Rs m | NA | 26,210 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 6,846 | 23.5% | |
Fx inflow | Rs m | 1,465 | 26,210 | 5.6% | |
Fx outflow | Rs m | 1,605 | 6,846 | 23.5% | |
Net fx | Rs m | -140 | 19,364 | -0.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 7,240 | 32.6% | |
From Investments | Rs m | -215 | -4,476 | 4.8% | |
From Financial Activity | Rs m | -985 | -2,620 | 37.6% | |
Net Cashflow | Rs m | 1,160 | 144 | 806.3% |
Indian Promoters | % | 0.0 | 69.1 | - | |
Foreign collaborators | % | 51.8 | 0.5 | 10,160.8% | |
Indian inst/Mut Fund | % | 20.3 | 19.0 | 106.5% | |
FIIs | % | 7.6 | 4.5 | 168.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 30.4 | 158.5% | |
Shareholders | 56,730 | 85,212 | 66.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | ALEMBIC PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.69% | -0.45% | 1.18% |
1-Month | -7.59% | -4.58% | -0.75% |
1-Year | -3.15% | 104.81% | 61.82% |
3-Year CAGR | -9.16% | 0.79% | 18.16% |
5-Year CAGR | 5.72% | 13.50% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the ALEMBIC PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ALEMBIC PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ALEMBIC PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.